Dr. Haile Mahteme

About Dr. Haile Mahteme

Dr. Haile Mahteme is a Consultant Surgical Oncologist specialising in upper gastrointestinal cancer surgery, cytoreductive surgery (CRS), and hyperthermic intraperitoneal chemotherapy (HIPEC) — a globally recognised HIPEC surgical oncologist in Riyadh, Saudi Arabia with decades of surgical and academic experience supporting international patients. He previously served as Associate Professor at Uppsala University's Department of Surgical Sciences in Sweden and is an internationally cited authority on peritoneal surface malignancies.

Consultant Surgical Oncologist specialising in Upper GI cancer surgery and HIPEC
Former Associate Professor — Department of Surgical Sciences, Uppsala University, Sweden
PhD in Surgical Sciences — Uppsala University, Sweden
Internationally recognised pioneer of CRS + HIPEC for peritoneal surface malignancies
Published lead or co-author on peritonectomy, gastric cancer HIPEC, and colorectal CRS+HIPEC outcomes research

Qualifications & Credentials

Medical Degrees

MD — Doctor of Medicine
PhD in Surgical Sciences — Uppsala University, Sweden
Surgical Residency

Fellowships & Special Training

Fellowship in Surgical Oncology
Advanced Training in Cytoreductive Surgery (CRS) and HIPEC
Subspecialty Training in Upper GI Oncologic Surgery

Certifications & Accreditations

European Board of Surgery Certification
Saudi Commission for Health Specialties (SCFHS) — Registered Consultant
European Society of Surgical Oncology (ESSO) — Member

Areas of Expertise

Major Conditions Treated

Gastric Cancer
Oesophageal Cancer
Pancreatic and Periampullary Cancers
Colorectal Cancer with Peritoneal Metastases
Pseudomyxoma Peritonei
Peritoneal Mesothelioma
Ovarian Cancer with Peritoneal Spread (Surgical)
Appendix Cancer
Hepatobiliary Malignancies
Upper GI Benign Complex Disease

Sub-specialties

Cytoreductive Surgery (CRS) + HIPEC: Combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei, colorectal peritoneal metastases, and gastric cancer with peritoneal spread — a globally cited HIPEC surgical oncologist in Riyadh for international patients.
Upper GI Cancer Surgery: Open and minimally invasive gastrectomy, oesophagectomy, and pancreatic resections for complex upper GI malignancies.
Peritoneal Surface Malignancies: Internationally recognised expertise in peritonectomy procedures, pseudomyxoma peritonei, and peritoneal mesothelioma.

Advanced Procedures & Treatments

Cytoreductive Surgery (CRS) with Peritonectomy
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Total and Subtotal Gastrectomy
Oesophagectomy (Open and Minimally Invasive)
Pancreaticoduodenectomy (Whipple Procedure)
Laparoscopic and Robotic Upper GI Oncology Surgery
Multivisceral Resection for Advanced Malignancies
Enhanced Recovery After Surgery (ERAS) for GI Cancer

Professional Experience

Current Affiliation

Consultant, Surgical Oncology & Upper GI — King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh, Saudi Arabia (Present)

Past Affiliations

Associate Professor, Department of Surgical Sciences — Uppsala University, Sweden (Past)
Consultant Surgical Oncologist — Uppsala University Hospital, Sweden (Past)

Academic & Research Roles

Former Associate Professor — Uppsala University, Department of Surgical Sciences
Principal and contributing author on multiple peer-reviewed HIPEC and surgical oncology publications
Cited author in Cochrane systematic reviews on pseudomyxoma peritonei CRS/HIPEC (2018)

Key Achievements

Internationally recognised HIPEC surgical oncology pioneer
Lead or co-author on Swedish peritonectomy + HIPEC experience
Contributing author on gastric cancer HIPEC and colorectal CRS+HIPEC cure rate analysis
Research on cisplatin HIPEC pharmacokinetics and pseudomyxoma peritonei CRS/HIPEC outcomes (Cochrane, 2018)

Awards & Recognitions

National & International Awards

Information not publicly available.

Professional Memberships

European Society of Surgical Oncology (ESSO)
Peritoneal Surface Oncology Group International (PSOGI)
Swedish Society of Surgical Oncology (alumni/affiliate)
Saudi Society of Surgical Oncology

Research & Publications

Published Papers (Selected)

Mahteme H, et al. Swedish Experience of Peritonectomy and Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology. 2008;15(3):745.
Mahteme H, et al. Gastric Cancer Treated with Cytoreductive Surgery and HIPEC. Acta Oncologica. 2012.
Mahteme H, et al. Colorectal Cancer Peritoneal Metastases — CRS + HIPEC Cure Rate Analysis. 2014. PubMed 24846340.
Mahteme H, et al. Cisplatin Pharmacokinetics During HIPEC.
Mahteme H, et al. Pseudomyxoma Peritonei — CRS and HIPEC. Cochrane Database of Systematic Reviews. 2018.

Ongoing Research & Clinical Interests

Cytoreductive surgery and HIPEC for peritoneal surface malignancies
Pseudomyxoma peritonei and peritoneal mesothelioma
HIPEC drug pharmacokinetics (cisplatin, mitomycin C, oxaliplatin)
Upper GI cancer surgical outcomes

Estimated Treatment Costs

Procedure / Consultation	Estimated Cost (INR)	Estimated Cost (USD)
Surgical Oncology Consultation	₹1,000 – ₹2,500	$12 – $30
Upper GI Cancer Surgery (Gastrectomy/Oesophagectomy)	₹4,50,000 – ₹9,00,000	$5,400 – $10,800
Cytoreductive Surgery (CRS)	₹5,00,000 – ₹10,00,000	$6,000 – $12,000
HIPEC Procedure (with CRS)	₹8,00,000 – ₹15,00,000	$9,600 – $18,000
Laparoscopic Oncology Surgery	₹3,00,000 – ₹7,00,000	$3,600 – $8,400

*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.

Frequently Asked Questions

1. What advanced technologies does Dr. Haile Mahteme use in Surgical Oncology — Upper GI & HIPEC treatment?

Dr. Haile Mahteme uses advanced surgical oncology technologies including cytoreductive surgery (CRS) with peritonectomy procedures, hyperthermic intraperitoneal chemotherapy (HIPEC), open and minimally invasive total gastrectomy and oesophagectomy, pancreaticoduodenectomy (Whipple procedure), laparoscopic and robotic upper GI oncology surgery, multivisceral resection for advanced malignancies, and enhanced recovery after surgery (ERAS) protocols for GI cancer. Virtual consultations and remote second opinions are also available to international patients through Cancer Rounds.

2. What conditions does Dr. Haile Mahteme specialize in treating?

Dr. Haile Mahteme specialises in Surgical Oncology and Upper GI cancer surgery with HIPEC expertise, treating gastric cancer, oesophageal cancer, pancreatic and periampullary cancers, colorectal cancer with peritoneal metastases, pseudomyxoma peritonei, peritoneal mesothelioma, ovarian cancer with peritoneal spread, appendix cancer, hepatobiliary malignancies, and complex benign upper GI disease. International patients seeking the best HIPEC surgical oncologist in India or Saudi Arabia benefit from his globally cited expertise.

3. How do I book an appointment with Dr. Haile Mahteme?

Appointments with Dr. Haile Mahteme can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.

4. Can international patients receive treatment from Dr. Haile Mahteme?

Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Haile Mahteme, including medical visa invitation letters, airport transfers, and local accommodation coordination.

5. What support is available for international patients?

International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.

6. Does Dr. Haile Mahteme offer second opinions for Surgical Oncology — Upper GI & HIPEC cases?

Yes. Second opinion consultations for Surgical Oncology and HIPEC cases — including CRS+HIPEC candidacy for peritoneal surface malignancies — can be arranged via Cancer Rounds, enabling international patients to review surgical options with Dr. Haile Mahteme.

About Dr. Haile Mahteme